|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A review of cyclic antidepressant-induced blood dyscrasias显示文摘 | Levin GM DeVane CL | 1992 | Ann Pharmacother1992，26，3： | 1 |
| 2 | Multiplenight time doses of valerian (Valeriana officinalis)had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers显示文摘 | Donovan JL Devane CL Chavin KD | 2004 | Drug Metab Dispos2004，32，12： | 1 |
| 3 | Clinical Pharmacokinetics of Quetiapine:An Atypical Antipsychotic显示文摘 | DeVane CL Nemeroff CB | 2001 | Clinical Pharmacokinetics2001，40，7： | 1 |
| 4 | Anxiety disorders in the 21st century: status,challenges,opportunities,and comorbidity with depression显示文摘 | Devane CL Chiao E Franklin M | 2005 | Am J Managed Care2005，，： | 1 |
| 5 | Fluoxetine-related death in a child with cytochrome P450 2D6 genetic deficiency显示文摘 | Salee FR DeVane CL and Ferrell RE | 2000 | J Child Adolesc Psychopharmacol2000，27，： | 1 |
| 6 | Mirtazapine in major depression with comorbid generalized anxiety disorder显示文摘 | Goodnick PJ Puig A DeVane CL | 1999 | J Clin Psychiatry1999，60，7： | 1 |
| 7 | Mirtazapine in major depression with comorbid generalized anxiety disorder显示文摘 | Goodnick PJ Puig A DeVane CL | 1999 | J Clin Psychiatry1999，60，7： | 1 |
| 8 | Anxiety Disorders in the 21st Century : Status, Challenges, Opportunities, and Comorbidity With Depression 显示文摘 | Devane CL Chiao E Franklin M | 2005 | Am J Manag Care2005，11，12： | 1 |
| 9 | Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone 显示文摘 | Devane CL | 2000 | Chirality2000，12，9： | 1 |
| 10 | Parmacokinetics of the newer antidepressants:Clinical relevance显示文摘 | Devane Cl | 1994 | Am J Med1994，97，6： | 1 |
| 11 | Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes 显示文摘 | Newport DJ Calamaras MR DeVane CL | 2007 | Am J Psychiatry2007，164，： | 1 |
| 12 | Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers 显示文摘 | Liston HL DeVane CL Boulton DW | 2002 | J Clin Psychopharmacol2002，22，2： | 1 |
| 13 | Anxiety disorders in the 21st century:Status,challenges,opportunities,and comorbidity with depression显示文摘 | Devane CL Chiao E Franklin M | 2005 | Am J Manag Care2005，11，12： | 1 |
| 14 | Mirtazapinin major depression with comorbid generalized anxiety disorder显示文摘 | Puig A Devane CL | 1999 | Clin psychiatry1999，60，： | 1 |
| 15 | Anxiety disorders in the 21st century : status, challenges, opportunities, and comorbidity with depression 显示文摘 | Devane CL Chiao E Franklin M | 2005 | The American Journal of Managed Care2005，11，12： | 1 |
| 16 | In vitro P -glycoprotein affinity for atypical and conventional antipsychotics 显示文摘 | Bouhon DW DeVane CL Liston HL | 2002 | Life Sci2002，71，： | 1 |
| 17 | Mirtazapinein major depression with comorbid generalized anxiety disorder显示文摘 | Coodnick PJ Puig A DeVane CL | 1999 | J Clin Psychiatry1999，60，3： | 1 |
| 18 | Pharmacokinetics of the newer antidepressants:Clinical relevance显示文摘 | DeVane CL | 1994 | Am J Med1994，97，6： | 1 |
| 19 | In vitro P- glycoproteinaffinity for atypical and conventional antipsychotics 显示文摘 | Bouhon DW DeVane CL Liston HL | 2002 | Life Sci2002，71，2： | 1 |
| 20 | In vitro P glycoprotein affinity for atypical and conventionalantipsychotics显示文摘 | Boulton DW Devane CL Liston HL | 2002 | Life Sci2002，71，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员